In Malaysia, IVF patients are frequently encouraged to add costly preimplantation genetic testing for aneuploidy (PGT-A) to their IVF treatment, intended to screen for chromosomal abnormalities. However, evidence on PGT-A’s effectiveness in increasing live birth rates is limited, particularly in certain age groups. Despite this, many IVF patients